Insider Trading activities at Viracta Therapeutics, Inc. (VIRX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Viracta Therapeutics, Inc. (VIRX) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Viracta Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1061027.

Total stock buying since 2005: $74,718,278.
Total stock sales since 2005: $88,033,307.
Total stock option exercises since 2005: $303,905.


31 insiders reported insider trading activities at Viracta Therapeutics, Inc. (VIRX):
Insider trading activities of Quinn William P.
Insider trading activities of Misfeldt Dayton
Insider trading activities of Barris Peter J
Insider trading activities of Bay City Capital Fund V Co-investment Fund Lp
Insider trading activities of Warburg Pincus Partners Llc
Insider trading activities of Ketchum Steven B
Insider trading activities of Chevallard Daniel R.
Insider trading activities of Biogen Idec Ma Inc
Insider trading activities of Rojkjaer Lisa
Insider trading activities of Gullotta Tina
Insider trading activities of Craig Adam R
Insider trading activities of Kerins Patrick J
Insider trading activities of Sandell Scott D
Insider trading activities of Hurwitz Edward
Insider trading activities of Pomerantz Roger
Insider trading activities of Elms Steve
Insider trading activities of Swisher Daniel N Jr
Insider trading activities of Warburg Pincus Llc
Insider trading activities of Royston Ivor
Insider trading activities of Baskett Forest
Insider trading activities of Parker Geoffrey M.
Insider trading activities of Nea 12 Gp, Llc
Insider trading activities of Semon Dominique
Insider trading activities of Kolluri Krishna Kittu
Insider trading activities of Leff Jonathan S
Insider trading activities of Bjerkholt Eric
Insider trading activities of Drant Ryan D
Insider trading activities of Wells James A
Insider trading activities of Champsi Farah
Insider trading activities of Ubs Oncology Impact Fund L.p.
Insider trading activities of Barrett M James

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Viracta Therapeutics, Inc. (VIRX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2024 0 $0 3,405 $2,492 143,902 $0
2023 0 $0 13,023 $15,737 161,806 $0
2022 0 $0 48,023 $142,114 142,696 $0
2021 8,000 $44,480 39,867 $191,809 142,286 $99,395
2020 6,000 $1,992 0 $0 0 $0
2019 2,512,000 $1,506,072 0 $0 0 $0
2018 40,000 $18,800 0 $0 0 $0
2017 481,500 $1,026,001 0 $0 0 $0
2016 65,745 $43,758 0 $0 0 $0
2015 1,800,000 $1,520,699 1,296,835 $4,515,628 0 $0
2014 0 $0 9,924,274 $69,497,620 39,389 $78,823
2013 0 $0 30,054 $151,667 55,054 $125,687
2011 9,600 $15,262 0 $0 0 $0
2010 179,736,352 $49,430,892 1,176,345 $1,121,505 0 $0
2009 0 $0 7,072,979 $12,364,735 0 $0
2007 1,362,400 $6,034,192 0 $0 0 $0
2006 1,628,206 $10,076,128 5,000 $30,000 0 $0
2005 714,286 $5,000,002 0 $0 0 $0

Table 2. Monthly summary of insider trading at Viracta Therapeutics, Inc. (VIRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2024-11 0 $0 0 $0 34,253 $0
2024-08 0 $0 0 $0 34,253 $0
2024-05 0 $0 0 $0 34,254 $0
2024-02 0 $0 3,405 $2,492 41,142 $0
2023-11 0 $0 3,720 $1,860 41,142 $0
2023-08 0 $0 3,512 $5,092 41,141 $0
2023-05 0 $0 3,635 $5,161 41,143 $0
2023-02 0 $0 2,156 $3,624 38,380 $0
2022-11 0 $0 5,648 $15,360 45,269 $0
2022-08 0 $0 19,224 $77,127 45,269 $0
2022-05 0 $0 16,758 $31,855 32,108 $0
2022-02 0 $0 6,393 $17,772 20,050 $0
2021-12 0 $0 0 $0 7,000 $6,300
2021-11 8,000 $44,480 39,867 $191,809 90,536 $0
2021-09 0 $0 0 $0 10,000 $9,000
2021-05 0 $0 0 $0 34,750 $84,095
2020-05 6,000 $1,992 0 $0 0 $0
2019-11 6,000 $2,196 0 $0 0 $0
2019-07 2,500,000 $1,500,000 0 $0 0 $0
2019-05 6,000 $3,876 0 $0 0 $0
2018-12 40,000 $18,800 0 $0 0 $0
2017-11 81,500 $226,001 0 $0 0 $0
2017-10 400,000 $800,000 0 $0 0 $0
2016-12 3,740 $14,476 0 $0 0 $0

Table 3. Detailed insider trading at Viracta Therapeutics, Inc. (VIRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2024-11-25 Pomerantz Roger Option Ex 9,034 .00 0
2024-11-25 Royston Ivor Option Ex 25,219 .00 0
2024-08-25 Pomerantz Roger Option Ex 9,034 .00 0
2024-08-25 Royston Ivor Option Ex 25,219 .00 0
2024-05-25 Pomerantz Roger Option Ex 9,035 .00 0
2024-05-25 Royston Ivor Option Ex 25,219 .00 0
2024-02-27 Chevallard Daniel R. (CFO and COO) Sale 3,405 .73 2,492
2024-02-25 Chevallard Daniel R. (CFO and COO) Option Ex 6,889 .00 0
2024-02-25 Pomerantz Roger (Director) Option Ex 9,034 .00 0
2024-02-25 Royston Ivor (Director) Option Ex 25,219 .00 0
2023-11-28 Chevallard Daniel R. (CFO and COO) Sale 3,720 .50 1,860
2023-11-25 Chevallard Daniel R. (CFO and COO) Option Ex 6,889 .00 0
2023-11-25 Pomerantz Roger (Director) Option Ex 9,034 .00 0
2023-11-25 Royston Ivor (Director) Option Ex 25,219 .00 0
2023-08-28 Chevallard Daniel R. (CFO and COO) Sale 3,512 1.45 5,092
2023-08-25 Chevallard Daniel R. (CFO and COO) Option Ex 6,888 .00 0
2023-08-25 Pomerantz Roger (Director) Option Ex 9,034 .00 0
2023-08-25 Royston Ivor (Director) Option Ex 25,219 .00 0
2023-05-25 Chevallard Daniel R. (CFO and COO) Sale 3,635 1.42 5,161
2023-05-25 Chevallard Daniel R. (CFO and COO) Option Ex 6,889 .00 0
2023-05-25 Pomerantz Roger (Director) Option Ex 9,035 .00 0
2023-05-25 Royston Ivor (Director) Option Ex 25,219 .00 0
2023-02-27 Rojkjaer Lisa (Chief Medical Officer) Sale 2,156 1.68 3,624
2023-02-25 Rojkjaer Lisa (Chief Medical Officer) Option Ex 4,127 .00 0
2023-02-25 Pomerantz Roger (Director) Option Ex 9,034 .00 0
2023-02-25 Royston Ivor (Director) Option Ex 25,219 .00 0
2022-11-28 Rojkjaer Lisa (Chief Medical Officer) Sale 2,116 2.72 5,753
2022-11-28 Chevallard Daniel R. (CFO and COO) Sale 3,532 2.72 9,607
2022-11-25 Rojkjaer Lisa (Chief Medical Officer) Option Ex 4,127 .00 0
2022-11-25 Chevallard Daniel R. (CFO and COO) Option Ex 6,889 .00 0
2022-11-25 Pomerantz Roger (Director) Option Ex 9,034 .00 0
2022-11-25 Royston Ivor (Director) Option Ex 25,219 .00 0
2022-08-26 Rojkjaer Lisa (Chief Medical Officer) Sale 2,190 4.01 8,786
2022-08-26 Chevallard Daniel R. (CFO and COO) Sale 3,655 4.02 14,678
2022-08-26 Royston Ivor (CEO & President) Sale 13,379 4.01 53,663
2022-08-25 Rojkjaer Lisa (Chief Medical Officer) Option Ex 4,127 .00 0
2022-08-25 Chevallard Daniel R. (CFO and COO) Option Ex 6,889 .00 0
2022-08-25 Pomerantz Roger (Director) Option Ex 9,034 .00 0
2022-08-25 Royston Ivor (CEO & President) Option Ex 25,219 .00 0
2022-05-26 Chevallard Daniel R. (CFO and COO) Sale 3,596 1.90 6,835
2022-05-26 Royston Ivor (CEO & President) Sale 13,162 1.90 25,020
2022-05-25 Chevallard Daniel R. (CFO and COO) Option Ex 6,889 .00 0
2022-05-25 Royston Ivor (CEO & President) Option Ex 25,219 .00 0
2022-02-28 Rojkjaer Lisa (Chief Medical Officer) Sale 2,395 2.78 6,658
2022-02-28 Chevallard Daniel R. (CFO and COO) Sale 3,998 2.78 11,114
2022-02-25 Rojkjaer Lisa (Chief Medical Officer) Option Ex 4,127 .00 0
2022-02-25 Chevallard Daniel R. (CFO and COO) Option Ex 6,889 .00 0
2022-02-25 Pomerantz Roger (Director) Option Ex 9,034 .00 0
2021-12-29 Royston Ivor (CEO & President) Option Ex 7,000 .90 6,300
2021-11-29 Rojkjaer Lisa (Chief Medical Officer) Sale 2,591 4.82 12,486
2021-11-29 Chevallard Daniel R. (CFO and COO) Sale 4,325 4.82 20,842
2021-11-29 Royston Ivor (CEO & President) Sale 15,833 4.82 76,299
2021-11-26 Rojkjaer Lisa (Chief Medical Officer) Sale 1,950 4.80 9,361
2021-11-26 Chevallard Daniel R. (CFO and COO) Sale 3,254 4.80 15,622
2021-11-26 Royston Ivor (CEO & President) Sale 11,914 4.80 57,199
2021-11-25 Rojkjaer Lisa (Chief Medical Officer) Option Ex 8,254 .00 0
2021-11-25 Chevallard Daniel R. (CFO and COO) Option Ex 13,777 .00 0
2021-11-25 Pomerantz Roger (Director) Option Ex 18,068 .00 0
2021-11-25 Royston Ivor (CEO & President) Option Ex 50,437 .00 0
2021-11-15 Royston Ivor (CEO & President) Buy 8,000 5.56 44,480
2021-09-28 Chevallard Daniel R. (CFO and COO) Option Ex 10,000 .90 9,000
2021-05-11 Rojkjaer Lisa (Chief Medical Officer) Option Ex 34,750 2.42 84,095
2020-05-29 Gullotta Tina (VP, Finance) Buy 6,000 .33 1,992
2019-11-29 Quinn William P. (See Remarks) Buy 6,000 .37 2,196
2019-07-15 Elms Steve (10% Owner) Buy 2,500,000 .60 1,500,000
2019-05-31 Quinn William P. (See Remarks) Buy 6,000 .65 3,876
2018-12-10 Quinn William P. (CFO,Sr.V.P. Finance, Corp.Dev.) Buy 40,000 .47 18,800
2017-11-06 Ubs Oncology Impact Fund L.p. Buy 16,200 2.77 44,874
2017-11-03 Ubs Oncology Impact Fund L.p. Buy 40,000 2.89 115,600
2017-11-02 Ubs Oncology Impact Fund L.p. Buy 25,300 2.59 65,527
2017-10-27 Misfeldt Dayton Buy 400,000 2.00 800,000
2016-12-09 Parker Geoffrey M. Buy 594 3.90 2,317
2016-12-08 Parker Geoffrey M. Buy 3,146 3.87 12,159
2016-05-26 Parker Geoffrey M. Buy 9,500 .47 4,455
2016-05-25 Parker Geoffrey M. Buy 22,505 .49 10,937
2016-05-24 Parker Geoffrey M. Buy 30,000 .46 13,890
2015-12-21 Misfeldt Dayton Buy 1,750,000 .84 1,470,000
2015-08-25 Swisher Daniel N Jr (President and CEO) Buy 12,216 1.01 12,338
2015-08-24 Swisher Daniel N Jr (President and CEO) Buy 12,784 1.01 12,911
2015-07-24 Misfeldt Dayton Sale 635,702 3.50 2,228,135
2015-07-24 Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) Sale 635,702 3.46 2,199,528
2015-07-24 Swisher Daniel N Jr (President and CEO) Buy 25,000 1.02 25,450
2015-07-24 Swisher Daniel N Jr (President and CEO) Sale 12,715 3.46 43,981
2015-07-24 Ketchum Steven B (Director) Sale 6,358 3.46 21,992
2015-07-24 Bjerkholt Eric (EVP, CFO & Corp. Secretary) Sale 6,358 3.46 21,992
2014-08-29 Nea 12 Gp, Llc (10% Owner) Sale 11,600 7.51 87,069
2014-08-29 Drant Ryan D (10% Owner) Sale 11,600 7.51 87,069
2014-08-29 Baskett Forest (10% Owner) Sale 11,600 7.51 87,069
2014-08-29 Kolluri Krishna Kittu (10% Owner) Sale 11,600 7.51 87,069
2014-08-29 Sandell Scott D (10% Owner) Sale 11,600 7.51 87,069
2014-08-29 Kerins Patrick J (10% Owner) Sale 11,600 7.51 87,069
2014-08-29 Barrett M James (10% Owner) Sale 11,600 7.51 87,069
2014-08-29 Barris Peter J (10% Owner) Sale 11,600 7.51 87,069
2014-08-28 Misfeldt Dayton Sale 200,000 7.88 1,577,000
2014-08-28 Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) Sale 200,000 7.88 1,577,000
2014-08-28 Nea 12 Gp, Llc (10% Owner) Sale 146,800 7.87 1,154,875
2014-08-28 Drant Ryan D (10% Owner) Sale 146,800 7.87 1,154,875
2014-08-28 Baskett Forest (10% Owner) Sale 146,800 7.87 1,154,875
2014-08-28 Kolluri Krishna Kittu (10% Owner) Sale 146,800 7.87 1,154,875
2014-08-28 Sandell Scott D (10% Owner) Sale 146,800 7.87 1,154,875
2014-08-28 Kerins Patrick J (10% Owner) Sale 146,800 7.87 1,154,875
2014-08-28 Barrett M James (10% Owner) Sale 146,800 7.87 1,154,875
2014-08-28 Barris Peter J (10% Owner) Sale 146,800 7.87 1,154,875
2014-08-27 Misfeldt Dayton Sale 100,700 8.16 822,014
2014-08-27 Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) Sale 100,700 8.16 822,014
2014-08-27 Nea 12 Gp, Llc (10% Owner) Sale 108,300 8.17 884,811
2014-08-27 Craig Adam R (EVP, Development & CMO) Sale 2,554 8.00 20,432
2014-08-27 Swisher Daniel N Jr (President and CEO) Sale 5,000 8.00 40,000
2014-08-27 Swisher Daniel N Jr (President and CEO) Option Ex 5,000 2.09 10,450
2014-08-27 Drant Ryan D (10% Owner) Sale 108,300 8.17 884,811
2014-08-27 Baskett Forest (10% Owner) Sale 108,300 8.17 884,811
2014-08-27 Kolluri Krishna Kittu (10% Owner) Sale 108,300 8.17 884,811
2014-08-27 Sandell Scott D (10% Owner) Sale 108,300 8.17 884,811
2014-08-27 Kerins Patrick J (10% Owner) Sale 108,300 8.17 884,811
2014-08-27 Barrett M James (10% Owner) Sale 108,300 8.17 884,811
2014-08-27 Bjerkholt Eric (EVP, CFO & Corp. Secretary) Sale 10,000 8.00 80,000
2014-08-27 Bjerkholt Eric (EVP, CFO & Corp. Secretary) Option Ex 10,000 1.74 17,400
2014-08-27 Barris Peter J (10% Owner) Sale 108,300 8.17 884,811
2014-08-12 Misfeldt Dayton Sale 37,100 6.77 251,241
2014-08-12 Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) Sale 37,100 6.77 251,241
2014-08-12 Nea 12 Gp, Llc (10% Owner) Sale 35,540 6.76 240,179
2014-08-12 Drant Ryan D (10% Owner) Sale 35,540 6.76 240,179
2014-08-12 Baskett Forest (10% Owner) Sale 35,540 6.76 240,179
2014-08-12 Kolluri Krishna Kittu (10% Owner) Sale 35,540 6.76 240,179
2014-08-12 Sandell Scott D (10% Owner) Sale 35,540 6.76 240,179
2014-08-12 Kerins Patrick J (10% Owner) Sale 35,540 6.76 240,179
2014-08-12 Barrett M James (10% Owner) Sale 35,540 6.76 240,179
2014-08-12 Barris Peter J (10% Owner) Sale 35,540 6.76 240,179
2014-08-11 Misfeldt Dayton Sale 31,600 6.90 218,103
2014-08-11 Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) Sale 31,600 6.90 218,103
2014-08-08 Misfeldt Dayton Sale 675,000 6.62 4,468,500
2014-08-08 Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) Sale 675,000 6.62 4,468,500
2014-08-08 Nea 12 Gp, Llc (10% Owner) Sale 675,000 6.62 4,468,500
2014-08-08 Drant Ryan D (10% Owner) Sale 675,000 6.62 4,468,500
2014-08-08 Baskett Forest (10% Owner) Sale 675,000 6.62 4,468,500
2014-08-08 Kolluri Krishna Kittu (10% Owner) Sale 675,000 6.62 4,468,500
2014-08-08 Sandell Scott D (10% Owner) Sale 675,000 6.62 4,468,500
2014-08-08 Kerins Patrick J (10% Owner) Sale 675,000 6.62 4,468,500
2014-08-08 Barrett M James (10% Owner) Sale 675,000 6.62 4,468,500
2014-08-08 Barris Peter J (10% Owner) Sale 675,000 6.62 4,468,500
2014-05-16 Swisher Daniel N Jr (President and CEO) Option Ex 24,389 2.09 50,973
2013-11-08 Ketchum Steven B Sale 10,503 5.08 53,365
2013-11-08 Ketchum Steven B Option Ex 10,503 2.09 21,951
2013-11-07 Ketchum Steven B Sale 19,551 5.03 98,302
2013-11-07 Ketchum Steven B Option Ex 19,551 2.09 40,861
2013-06-18 Swisher Daniel N Jr (President and CEO) Option Ex 25,000 2.52 62,875
2011-11-28 Swisher Daniel N Jr (President and CEO) Buy 2,500 1.14 2,849
2011-11-21 Swisher Daniel N Jr (President and CEO) Buy 2,100 1.18 2,478
2011-07-15 Swisher Daniel N Jr (President and CEO) Buy 5,000 1.99 9,935
2010-10-08 Bjerkholt Eric (Sr. VP, CFO & Corp. Secretary) Buy 100,000 .31 30,900
2010-06-30 Misfeldt Dayton Buy 23,824,450 .28 6,551,723
2010-06-30 Bay City Capital Fund V Co-investment Fund Lp (10% Owner) Buy 23,824,450 .28 6,551,723
2010-06-30 Swisher Daniel N Jr (President and CEO) Buy 476,487 .28 131,033
2010-06-30 Drant Ryan D (10% Owner) Buy 23,824,451 .28 6,551,724
2010-06-30 Ketchum Steven B (Sr. Vice President, R & D) Buy 238,243 .28 65,516
2010-06-30 Baskett Forest (10% Owner) Buy 23,824,451 .28 6,551,724
2010-06-30 Kolluri Krishna Kittu (10% Owner) Buy 23,824,451 .28 6,551,724
2010-06-30 Sandell Scott D (10% Owner) Buy 23,824,451 .28 6,551,724
2010-06-30 Kerins Patrick J (10% Owner) Buy 23,824,451 .28 6,551,724
2010-06-30 Champsi Farah (Other) Buy 11,912,224 .28 3,275,861
2010-06-30 Bjerkholt Eric (Sr. VP, CFO & Corp. Secretary) Buy 238,243 .28 65,516
2010-04-30 Semon Dominique Sale 382,542 .98 373,743
2010-02-25 Semon Dominique Sale 793,803 .94 747,762
2009-12-14 Hurwitz Edward (Director) Sale 2,232,464 2.01 4,485,020
2009-12-14 Champsi Farah (10% Owner) Sale 2,232,464 2.01 4,485,020
2009-12-11 Semon Dominique Sale 1,508,051 2.02 3,046,263
2009-07-21 Warburg Pincus Llc (10% Owner) Sale 347,655 .28 95,605
2009-07-20 Warburg Pincus Llc (10% Owner) Sale 110,200 .28 30,966
2009-07-17 Warburg Pincus Llc (10% Owner) Sale 7,625 .30 2,310
2009-07-16 Warburg Pincus Llc (10% Owner) Sale 134,500 .30 40,888
2009-07-15 Warburg Pincus Llc (10% Owner) Sale 42,720 .32 13,670
2009-07-14 Warburg Pincus Llc (10% Owner) Sale 107,300 .32 34,443
2009-07-13 Warburg Pincus Llc (10% Owner) Sale 350,000 .37 130,550
2007-05-30 Warburg Pincus Partners Llc (10% Owner) Buy 677,200 4.43 2,999,996
2007-05-30 Leff Jonathan S (Director) Buy 677,200 4.43 2,999,996
2007-03-21 Swisher Daniel N Jr (President and CEO) Buy 5,000 4.26 21,300
2007-03-13 Bjerkholt Eric (Sr. VP, Corp. Dev. & Finance) Buy 3,000 4.30 12,900
2006-12-14 Swisher Daniel N Jr (President and CEO) Buy 17,900 4.25 76,128
2006-09-08 Wells James A Sale 5,000 6.00 30,000
2006-03-17 Warburg Pincus Partners Llc (10% Owner) Buy 805,153 6.21 5,000,000
2006-03-17 Leff Jonathan S (Director) Buy 805,153 6.21 5,000,000
2005-09-27 Biogen Idec Ma Inc (10% Owner) Buy 714,286 7.00 5,000,002

Insider trading activities including stock purchases, stock sales, and option exercises of VIRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Viracta Therapeutics, Inc. (symbol VIRX, CIK number 1061027) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.